PATH

PATH is a Seattle-based global health nonprofit founded in 1976, originally as the Program for Appropriate Technology in Health. It's best known for innovations like MenAfriVac, the meningitis A vaccine it developed with the Serum Institute of India that has immunized hundreds of millions across Africa's meningitis belt.

Yes, it's a 501(c)(3) nonprofit that relies heavily on grants from major funders such as the Bill & Melinda Gates Foundation, along with governments and multilateral agencies. Rather than direct patient care, it funds product development and health-system strengthening work in low-income countries.

Beyond vaccines, PATH pioneered public-health tools like the vaccine vial monitor — the small heat-sensitive sticker on vaccine vials that shows whether doses have been kept cool enough — and helped scale up auto-disable syringes that can't be reused. These low-cost inventions have become standards used worldwide.

Its core priorities include vaccine development and delivery, maternal and child health, malaria and other infectious diseases, and strengthening health systems in Africa and Asia. The organization acts as a bridge between pharma companies, governments, and communities to get tools approved and distributed.